Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver

Journal of Nuclear Medicine

Volumn 37, Issue 4 SUPPL., 1996, Pages

  Daghighian, Farhad ^a   Humm, John L ^a   Macapinlac, Homer A ^a   Zhang, Jiaju ^a   Izzo, Julie ^a   Finn, Ronald ^a   Kemeny, Nancy ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Auger electron; DNA level dosimetry; Iododeoxyuridine

Indexed keywords

IDOXURIDINE; RADIOACTIVE IODINE;

ARTICLE; BONE MARROW; COLORECTAL TUMOR; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER; LIVER TUMOR; METASTASIS; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIOMETRY; SCINTISCANNING;

BONE MARROW; COLORECTAL NEOPLASMS; HEPATIC ARTERY; HUMANS; IDOXURIDINE; INJECTIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; LIVER; LIVER NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE;

EID: 0030117608     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 131I. Radiat Res 1971;47:94-109.
2. 125I in cell DNA at -196°C. Int J Radiat Biol 1973;24:363-375.
3. Hofer KG. Radiation biology and potential therapeutic applications of radionuclides. Bull Cancer (Paris) 1980;67:343-353.
4. Martin RF, Haseltine WA. Range of radiochemical damage to DNA with decay of iodine-125. Science 1981;213:896-898.
5. 3H]TdR incorporated in the DNA of human lymphoblast cells. Mutat Res 1983;111:387-404.
6. Kassis AI, Howell RW, Sastry KSR, Adelstein SJ. Positional effects of Auger decays in mammalian cells in culture. In: Baverstock KF, Charlton DE, eds. DNA damage by Auger emitters. London: Taylor and Francis; 1988:1-13.
7. 125I: a review. Report no. 1 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992;19:1361-1370.
8. 3H: nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol 1975;28:225-241.
9. 125I in mammalian cells. Radiat Res 1987;111:305-318.
10. Younis A-RS, Watt DE. The quality of ionising radiations emitted by radionuclides incorporated into mammalian cells. Phys Med Biol 1989;34:821-834.
11. 125I decays. Radiat Res 1986;107: 163-171.
12. 125I]iodo-2′-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993;34:1175-1183.
13. 125I]iodo-2′-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. I. Pilot clinical trial. J Nucl Med 1996;37(suppl):25S-29S.
14. Humm JL, Howell RW, Rao DV. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1994;21:1901-1915.
15. Loevinger R, Budinger TF, Watson EE, eds. MIRD primer for absorbed dose calculations, revised. Reston, VA: Society of Nuclear Medicine; 1991.
16. 125I decay in microorganisms. Curr Top Radiat Res Q 1978;12:355-368.
17. Daghighian F, Pentlow KS, Larson SM, et al. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumor with applications to microdosimetry: positron emission tomography studies of iodine-124-3F8 monoclonal antibody in glioma. Eur J Nucl Med 1993;20:402-409.
18. Steele G. Growth kinetics of tumours. In: Steele G, Adams G, eds. The biological basis of radiotherapy, 2nd ed. Oxford: Clarandon Press; 1977.
19. Siegel JA, Wessels BW, Watson EE, et al. Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconj Radiopharm 1990;3:213-233.
20. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med 1993;34:689-694.
21. Kiefer J. Biological radiation effects. Berlin: Springer-Verlag; 1990.